P450-catalyzed enantiodivergent kinetic oxidation to access chiral haloalcohols

AI Insight

Researchers developed a method using engineered P450 enzymes to catalyze enantiodivergent kinetic oxidation reactions, enabling the selective production of both enantiomers of chiral haloalcohols from the same starting materials. By engineering different variants of cytochrome P450 enzymes, they achieved control over the stereochemical outcome of oxidation reactions, allowing access to either the R or S enantiomer with high selectivity. This biocatalytic approach provides a sustainable alternative to traditional chemical synthesis for producing these important chiral building blocks.

Why it matters

Chiral haloalcohols are valuable intermediates in pharmaceutical synthesis and fine chemical production. This enzymatic method offers a greener, more selective approach to accessing both enantiomers without requiring separate synthetic routes, potentially reducing waste and improving efficiency in drug manufacturing.